Masataka Hirabayashi

Efficacy and safety of nivolumab in previously treated patients with non-small cell lung cancer: A multicenter retrospective cohort study

Daichi Fujimoto, Hiroshige Yoshioka, Yuki Kataoka et al. · Lung Cancer · 2018 · 142 citations

Medicine, Clinical Trials, Immune Checkpoint Inhibitor +6

Pseudoprogression in Previously Treated Patients with Non–Small Cell Lung Cancer Who Received Nivolumab Monotherapy

Daichi Fujimoto, Hiroshige Yoshioka, Yuki Kataoka et al. · Journal of Thoracic Oncology · 2018 · 116 citations

Medicine, Cancer Management, Nivolumab Monotherapy +6

A Randomized, Placebo-Controlled Trial of Acupuncture in Patients With Chronic Obstructive Pulmonary Disease (COPD)

Masao Suzuki, Shigeo Muro, Takashi Omori et al. · Archives of Internal Medicine · 2012 · 93 citations

Detection of the T790M mutation of <i>EGFR</i> in plasma of advanced non-small cell lung cancer patients with acquired resistance to tyrosine kinase inhibitors (West Japan oncology group 8014LTR study)

Takayuki Takahama, Kazuko Sakai, Masayuki Takeda et al. · Oncotarget · 2016 · 71 citations · Full text

Sensitive and Specific New Enzyme-Linked Immunosorbent Assay for N-ERC/Mesothelin Increases its Potential as a Useful Serum Tumor Marker for Mesothelioma

Kazu Shiomi, Yoshiaki Hagiwara, Kouji Sonoue et al. · Clinical Cancer Research · 2008 · 64 citations · Full text